Metal complexes as structural templates for targeting proteins

Current Opinion in Chemical Biology

Volumn 19, Issue 1, 2014, Pages 76-81

  Dörr, Markus ^a   Meggers, Eric ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METAL COMPLEX; ENZYME INHIBITOR; METAL; METALLOPROTEIN; PROTEIN BINDING;

COMPLEX FORMATION; CRYSTAL STRUCTURE; GEOMETRY; LIGAND BINDING; NONHUMAN; ORGANIC CHEMISTRY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; CHEMISTRY; HUMAN; METABOLISM; PROTEIN CONFORMATION;

ENZYME INHIBITORS; HUMANS; METALLOPROTEINS; METALS; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 84897099980     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2014.01.005     Document Type: Review

References (43)

1. Kilah N.L., Meggers E. Sixty years young: the diverse biological activities of metal polypyridyl complexes pioneered by Francis P. Dwyer. Aust J Chem 2012, 65:1325-1332.
2. De Almeida A., Oliveira B.L., Correira J.D.G., Soveral G., Casini A. Emerging protein targets for metal-based pharmaceutical agents: an update. Coord Chem Rev 2013, 257:2689-2704.
3. Kilpin K.J., Dyson P.J. Enzyme inhibition by metal complexes: concepts, strategies and applications. Chem Sci 2013, 4:1410-1419.
4. Patra M., Gasser G. Organometallic compounds: an opportunity for chemical biology?. ChemBioChem 2012, 13:1232-1252.
5. Hillard E.A., Jaouen G. Bioorganometallics: future trends in drug discovery, analytical chemistry, and catalysis. Organometallics 2011, 30:20-27.
6. Barry N.P.E., Sadler P.J. Exploration of the medical periodic table: towards new targets. Chem Commun 2013, 49:5106-5131.
7. Sasmal P.K., Streu C.N., Meggers E. Metal complex catalysis in living biological systems. Chem Commun 2013, 49:1581-1587.
8. Schatzschneider U. Photoactivated biological activity of transition-metal complexes. Eur J Inorg Chem 2010, 1451-1467.
9. Wang P., Leung C., Ma D., Lu W., Che C.-M. Organoplatinum(II) complexes with nucleobase motifs as inhibitors of human topoisomerase II catalytic activity. Chem Asian J 2010, 5:2271-2280.
10. Sun R.W.-Y., Li C.K., Ma D., Yan J.J., Lok C., Leung C., Zhu N., Che C.-M. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure. Chem Eur J 2010, 16:3097-3113.
11. Amin J., Chuckowree I., Tizzard G.J., Coles S.J., Wang M., Bingham J.P., Hartley J.A., Spencer J. Targeting epidermal growth factor receptor with ferrocene-based kinase inhibitors. Organometallics 2013, 32:509-513.
12. Spencer J., Amin J., Callear S.K., Tizzard G.J., Coles S.J., Coxhead P., Guille M. Synthesis and evaluation of metallocene containing methylidene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors. Metallomics 2011, 3:600-608.
13. Spencer J., Amin J., Coxhead P., McGeehan J., Richards C.J., Tizzard G.J., Coles S.J., Bingham J.P., Hartley J.A., Feng L., et al. Size does matter, sterically demanding metallocene-substituted 3-methylidene-oxindoles exhibit poor kinase inhibitory action. Organometallics 2011, 30:3177-3181.
14. Spencer J., Amin J., Wang M., Packham G., Alwi S.S.S., Tizzard G.J., Coles S.J., Paranal R.M., Bradner J.E., Heightman T.D. Synthesis and biological evaluation of JAHAs: ferrocene-based histone deacetylase inhibitors. ACS Med Chem Lett 2011, 2:358-362.
15. Spencer, et al. Click JAHAs: conformationally restricted ferrocene-based histone deacetylase inhibitors. Med Chem Commun 2012, 3:61-64.
16. Salmon A.J., Williams M.L., Innocenti A., Vullo D., Supuran C.T., Poulsen S.-A. Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing organometallic moiety. Bioorg Med Chem Lett 2007, 17:5032-5035.
17. Loughrey B.T., Williams M.L., Healy P.C., Innocenti A., Vullo D., Supuran C.T., Parsons P.G., Poulsen S.-A. Novel organometallic cationic ruthenium(II) pentamethylcyclopentadienyl benzenesulfonamide complexes targeted to inhibit carbonic anhydrase. J Biol Inorg Chem 2009, 14:935-945.
18. Salmon A.J., Williams M.L., Wu Q.K., Morizzi J., Gregg D., Charman S.A., Vullo D., Supuran C.T., Poulsen S. Metallocene-based inhibitors of cancer-associated carbonic anhydrase enzymes IX and XII. J Med Chem 2012, 55:5506-5517.
19. Salmon A.J., Williams M.L., Hofmann A., Poulsen S. Protein crystal structures with ferrocene and ruthenocene-based enzyme inhibitors. Chem Commun 2012, 48:2328-2330.
20. Payen O., Top S., Vessières A., Brulé E., Lauzier A., Plamont M., McGlinchey M.J., Müller-Brunz H., Jaouen G. Synthesis and biological activity of ferrocenyl derivatives of the non-steroidal antiandrogens flutamide and bicalutamide. J Organomet Chem 2011, 696:1049-1056.
21. Patra M., Gasser G., Wenzel M., Merz K., Bandow J.E., Metzler-Nolte N. Synthesis of optically active ferrocene-containing platensimycin derivatives with a C6-C7 substitution pattern. Eur J Inorg Chem 2011, 2011:3295-3302.
22. Pigeon P., Top S., Vessières A., Huché M., Görmen M., El Arbi M., Plamont M., McGlinchey M.J., Jaouen G. A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells. New J Chem 2011, 35:2212-2218.
23. Cázares Marinero J.J., Lapierre M., Cavaillès V., Saint-Fort R., Vessières A., Top S., Jaouen G. Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen - SAHA hybrids and related species. Dalton Trans 2013, 42:15489-15501.
24. Cázares-Marinero J.J., Buriez O., Labbe E., Top S., Amatore C., Jaouen G. Synthesis, characterization, and antiproliferative activities of novel ferrocenophanic suberamides against human triple-negative MDA-MB-231 and hormone-dependent MCF-7 breast cancer cells. Organometallics 2013, 32:5926-5934.
25. Patra M., Gasser G., Pinto A., Merz K., Ott I., Bandow J.E., Metzler-Nolte N. Synthesis and biological evaluation of chromium bioorganometallics based on the antibiotic platensimycin lead structure. ChemMedChem 2009, 4:1930-1938.
26. Bielig H., Velder J., Saiai A., Menning M., Meemboor S., Kalka-Moll W., Krönke M., Schmalz H., Kufer T.A. Anti-inflammatory arene-chromium complexes acting as specific inhibitors of NOD2 signalling. ChemMedChem 2010, 5:2065-2071.
27. 99mTc) arylsulfonamide, arylsulfamide, and arylsulfamate conjugates for selective targeting of human carbonic anhydrase IX. Angew Chem Int Ed 2012, 51:3354-3357.
28. 99mTc). Organometallics 2012, 31:6880-6886.
29. Monnard F.W., Heinisch T., Nogueira E.S., Schirmer T., Ward T.R. Human carbonic anhydrase II as a host for piano-stool complexes bearing a sulfonamide anchor. Chem Commun 2011, 47:8238-8240.
30. Ong J.X., Yap C.W., Ang WH Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B. Inorg Chem 2012, 51:12483-12492.
31. 3 adenosine receptors. Chem Eur J 2013, 19:8321-8330.
32. Wähler K., Kräling K., Steuber H., Meggers E. Non-ATP-mimetic organometallic protein kinase inhibitor. ChemistryOpen 2013, 2:180-185.
33. Streib M., Kräling K., Richter K., Xie Xiulan, Steuber H., Meggers E. Organometallic inhibitor for the human repair enzyme 7,8-dihydro-8-oxoguanine triphosphatase. Angew Chem Int Ed 2014, 53:305-309.
34. Feng, et al. Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors. J Am Chem Soc 2011, 133:5976-5986.
35. Blanck S., Maksimoska J., Baumeister J., Harms K., Marmorstein R., Meggers E. The art of filling protein pockets efficiently with octahedral metal complexes. Angew Chem Int Ed 2012, 51:5244-5246.
36. Wilbuer A., Vlecken D.H., Schmitz D.J., Kräling K., Harms K., Bagowski C.P., Meggers E. Iridium complex with antiangiogenic properties. Angew Chem Int Ed 2010, 49:3839-3842.
37. Mollin S., Blanck S., Harms K., Meggers E Cyclometalated phenylquinoline rhodium complexes as protein kinase inhibitors. Inorg Chim Acta 2012, 393:261-268.
38. Dieckmann S., Riedel R., Harms K., Meggers E Pyridocarbazole-rhodium(III) complexes as protein kinase inhibitors. Eur J Inorg Chem 2012, 813-821.
39. Leung C., Zhong H., Yang H., Cheng Z., Chan D.S., Ma V.P., Abagyan R., Wong C., Ma D. A metal-based inhibitor of tumor necrosis factor-α. Angew Chem Int Ed 2012, 51:9010-9014.
40. Zhong H., Yang H., Chan D.S., Leung C., Wang H., Ma D. A metal-based inhibitor of NEDD8-activating enzyme. PLoS One 2012, 7:e49574.
41. Oliveira B.L., Moreira I.S., Fernandes P.A., Ramos M.J., Santos I., Correira J.D.G. Theoretical studies on the binding of rhenium(I) complexes to inducible nitric oxide synthase. J Mol Graph Model 2013, 45:13-25.
42. Meggers E. Exploring biologically relevant chemical space with metal complexes. Curr Opin Chem Biol 2007, 11:287-292.
43. Kastl A., Wilbuer A., Merkel A.L., Feng L., Di Fazio P., Ocker M., Meggers E. Dual anticancer activity in a single compound: visible light-induced apoptosis by an antiangiogenic iridium complex. Chem Commun 2012, 48:1863-1865.